View Regulatory Gene Expression in Mafb Deficient Macrophages
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
UNIVERSITY of CALIFORNIA, SAN DIEGO Towards an Understanding of Inflammation in Macrophages a Dissertation Submitted in Partial
UNIVERSITY OF CALIFORNIA, SAN DIEGO Towards an Understanding of Inflammation in Macrophages A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Dawn Xiaobin Zhang Committee in charge: Professor Christopher L. Glass, Chair Professor Jack Bui Professor Ronald M. Evans Professor Richard L. Gallo Professor Joseph L. Witztum 2014 Copyright Dawn Xiaobin Zhang, 2014 All rights reserved. This Dissertation of Dawn Xiaobin Zhang is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2014 iii DEDICATION To my family and the love of my life, Matthew. iv EPIGRAPH How often have I said to you that when you have eliminated the impossible, whatever remains, however improbable, must be the truth? -Sherlock Holmes, From The Sign of the Four, Sir Arthur Conan Doyle v TABLE OF CONTENTS Signature Page ……………………………………………………………….. iii Dedication ……………………………………………………….…………….. iv Epigraph ……………………………………………………………………….. v Table of Contents ………………………………………………………….….. vi List of Figures ………………………………………………………….………. viii List of Tables ………………………………………………………….…….…. x Acknowledgements …………………………………….…………………..…. xi Vita …………………………………….……………………………………..…. xiii Abstract of the Dissertation ………………………………..…………………. xv Chapter I: Introduction: Towards an Understanding of Cell-Specific Function of Signal-Dependent Transcription Factors ……....…....…... 1 A. Abstract ……....…....………………………………...…………….. 2 B. Introduction -
Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice. -
The Viral Oncoproteins Tax and HBZ Reprogram the Cellular Mrna Splicing Landscape
bioRxiv preprint doi: https://doi.org/10.1101/2021.01.18.427104; this version posted January 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape Charlotte Vandermeulen1,2,3, Tina O’Grady3, Bartimee Galvan3, Majid Cherkaoui1, Alice Desbuleux1,2,4,5, Georges Coppin1,2,4,5, Julien Olivet1,2,4,5, Lamya Ben Ameur6, Keisuke Kataoka7, Seishi Ogawa7, Marc Thiry8, Franck Mortreux6, Michael A. Calderwood2,4,5, David E. Hill2,4,5, Johan Van Weyenbergh9, Benoit Charloteaux2,4,5,10, Marc Vidal2,4*, Franck Dequiedt3*, and Jean-Claude Twizere1,2,11* 1Laboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.2Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.3Laboratory of Gene Expression and Cancer, GIGA Institute, University of Liege, Liege, Belgium.4Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. 5Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.6Laboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, University of Lyon, Lyon, France.7Department of Pathology and Tumor Biology, Kyoto University, Japan.8Unit of Cell and Tissue Biology, GIGA Institute, University of Liege, Liege, Belgium.9Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Catholic University of Leuven, Leuven, Belgium.10Department of Human Genetics, CHU of Liege, University of Liege, Liege, Belgium.11Lead Contact. *Correspondence: [email protected]; [email protected]; [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.01.18.427104; this version posted January 18, 2021. -
Characterization of the Macrophage Transcriptome in Glomerulonephritis-Susceptible and -Resistant Rat Strains
Genes and Immunity (2011) 12, 78–89 & 2011 Macmillan Publishers Limited All rights reserved 1466-4879/11 www.nature.com/gene ORIGINAL ARTICLE Characterization of the macrophage transcriptome in glomerulonephritis-susceptible and -resistant rat strains K Maratou1, J Behmoaras2, C Fewings1, P Srivastava1, Z D’Souza1, J Smith3, L Game4, T Cook2 and T Aitman1 1Physiological Genomics and Medicine Group, MRC Clinical Sciences Centre, Imperial College London, London, UK; 2Centre for Complement and Inflammation Research, Imperial College London, London, UK; 3Renal Section, Imperial College London, London, UK and 4Genomics Laboratory, MRC Clinical Sciences Centre, London, UK Crescentic glomerulonephritis (CRGN) is a major cause of rapidly progressive renal failure for which the underlying genetic basis is unknown. Wistar–Kyoto (WKY) rats show marked susceptibility to CRGN, whereas Lewis rats are resistant. Glomerular injury and crescent formation are macrophage dependent and mainly explained by seven quantitative trait loci (Crgn1–7). Here, we used microarray analysis in basal and lipopolysaccharide (LPS)-stimulated macrophages to identify genes that reside on pathways predisposing WKY rats to CRGN. We detected 97 novel positional candidates for the uncharacterized Crgn3–7. We identified 10 additional secondary effector genes with profound differences in expression between the two strains (45-fold change, o1% false discovery rate) for basal and LPS-stimulated macrophages. Moreover, we identified eight genes with differentially expressed alternatively spliced isoforms, by using an in-depth analysis at the probe level that allowed us to discard false positives owing to polymorphisms between the two rat strains. Pathway analysis identified several common linked pathways, enriched for differentially expressed genes, which affect macrophage activation. -
Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma
fcell-09-708819 August 9, 2021 Time: 10:32 # 1 ORIGINAL RESEARCH published: 11 August 2021 doi: 10.3389/fcell.2021.708819 Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma Lixu Zhu1,2,3,4 and Wenzhi Guo1,2,3,4* 1 Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2 Key Laboratory of Hepatobiliary and Pancreatic Surgery and Digestive Organ Transplantation of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 3 Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities, Zhengzhou, China, 4 Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou, China Edited by: Ritu Kulshreshtha, Hepatocellular carcinoma (HCC) has the highest incidence and mortality of any Indian Institute of Technology Delhi, malignancy in the world. Immunotherapy has been a major breakthrough for HCC India treatment, but immune checkpoint inhibitors (ICIs) are effective in only a small Reviewed by: Hernando Lopez Bertoni, percentage of HCC patients. In the present study, we screened programmed cell death Johns Hopkins Medicine, protein 1 (PD-1) -negative HCC samples, which are frequently resistant to ICIs, and United States Jingying Zhou, identified their methylation and transcription characteristics through the assessment The Chinese University of Hong Kong, of differential gene methylation and gene expression. We also screened for potential China targeted therapeutic drugs using the DrugBank database. Finally, we used a LASSO *Correspondence: (least absolute shrinkage and selection operator) regression analysis to construct Wenzhi Guo [email protected] a prognostic model based on three differentially methylated and expressed genes (DMEGs). -
Bioinformatics Analysis to Screen Key Genes in Papillary Thyroid Carcinoma
ONCOLOGY LETTERS 19: 195-204, 2020 Bioinformatics analysis to screen key genes in papillary thyroid carcinoma YUANHU LIU1*, SHUWEI GAO2*, YAQIONG JIN2, YERAN YANG2, JUN TAI1, SHENGCAI WANG1, HUI YANG2, PING CHU2, SHUJING HAN2, JIE LU2, XIN NI1,2, YONGBO YU2 and YONGLI GUO2 1Department of Otolaryngology, Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health; 2Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, P.R. China Received April 22, 2019; Accepted September 24, 2019 DOI: 10.3892/ol.2019.11100 Abstract. Papillary thyroid carcinoma (PTC) is the most verifying their potential for clinical diagnosis. Taken together, common type of thyroid carcinoma, and its incidence has the findings of the present study suggest that these genes and been on the increase in recent years. However, the molecular related pathways are involved in key events of PTC progression mechanism of PTC is unclear and misdiagnosis remains a and facilitate the identification of prognostic biomarkers. major issue. Therefore, the present study aimed to investigate this mechanism, and to identify key prognostic biomarkers. Introduction Integrated analysis was used to explore differentially expressed genes (DEGs) between PTC and healthy thyroid tissue. To Thyroid carcinoma is the most common malignancy of investigate the functions and pathways associated with DEGs, the head and neck, and accounts for 91.5% of all endocrine Gene Ontology, pathway and protein-protein interaction (PPI) malignancies (1). -
Identification of Novel Diagnostic Biomarkers for Thyroid Carcinoma
www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 67), pp: 111551-111566 Research Paper Identification of novel diagnostic biomarkers for thyroid carcinoma Xiliang Wang1,2, Qing Zhang1, Zhiming Cai1, Yifan Dai3 and Lisha Mou1 1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China 2Department of Biochemistry in Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China 3Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing 210029, China Correspondence to: Lisha Mou, email: [email protected] Keywords: thyroid carcinoma; bioinformatics; dysregulation network; biomarker Received: June 27, 2017 Accepted: November 19, 2017 Published: December 04, 2017 Copyright: Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Thyroid carcinoma (THCA) is the most universal endocrine malignancy worldwide. Unfortunately, a limited number of large-scale analyses have been performed to identify biomarkers for THCA. Here, we conducted a meta-analysis using 505 THCA patients and 59 normal controls from The Cancer Genome Atlas. After identifying differentially expressed long non-coding RNA (lncRNA) and protein coding genes (PCG), we found vast difference in various lncRNA-PCG co-expressed pairs in THCA. A dysregulation network with scale-free topology was constructed. Four molecules (LA16c-380H5.2, RP11-203J24.8, MLF1 and SDC4) could potentially serve as diagnostic biomarkers of THCA with high sensitivity and specificity. -
Rank Aggregation Via the Cross Entropy Algorithm
Finding cancer genes through meta-analysis of of the individual microarray studies were hybridized with the A®ymetrix GeneChip Human Genome HG-U133A and record expression levels for 22,283 Probe IDs. To make our ¯nal results meaningful and comprehensive at the same time, we decided to focus on microarray experiments that study di®erent types of cancer in humans. The goal of our meta-analysis is to identify genetic factors which are common across di®erent types and stages of cancer. For that purpose, we have selected 20 di®erent cancer-related microarray experiments which are included in the contest meta-dataset and have explicit cell type groupings necessary for detecting di®erentially expressed genes. Here, we list the selected experiment IDs along with the number of samples in each experiment in the parenthesis: E-MEXP-72 (20), E-MEXP-83 (22), E-MEXP-76 (17), E-MEXP-97 (24), E-MEXP-121 (30), E-MEXP-149 (20), E-MEXP-231 (58), E-MEXP-353 (96), E-TABM-26 (57), E-MEXP-669 (24), GSE4475 (221), GSE1456 (159), GSE5090 (17), GSE1420 (24), GSE1577 (29), GSE1729 (43), GSE2485 (18), GSE2603 (21), GSE3585 (12), GSE4127 (29). The total number of selected arrays is 941 (about 1/6 of the overall number of samples in the meta-dataset). One can refer to ArrayExpress database which provides public access to the microarray data from these experiments (http://www.ebi.ac.uk/arrayexpress/ ). 3 Methodology The proposed meta-analysis approach to microarray data is a two-step procedure: 1. Individual Analysis. By analyzing each microarray dataset individually, a set of \interesting" genes (top-50 Probe IDs) that exhibit the largest di®erences in terms of expression values between the groups is obtained for each dataset. -
Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham a Thesis Submitted in Conformity
Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department of Molecular Genetics University of Toronto © Copyright by Edward James Higginbotham 2020 i Abstract Characterizing Genomic Duplication in Autism Spectrum Disorder Edward James Higginbotham Master of Science Graduate Department of Molecular Genetics University of Toronto 2020 Duplication, the gain of additional copies of genomic material relative to its ancestral diploid state is yet to achieve full appreciation for its role in human traits and disease. Challenges include accurately genotyping, annotating, and characterizing the properties of duplications, and resolving duplication mechanisms. Whole genome sequencing, in principle, should enable accurate detection of duplications in a single experiment. This thesis makes use of the technology to catalogue disease relevant duplications in the genomes of 2,739 individuals with Autism Spectrum Disorder (ASD) who enrolled in the Autism Speaks MSSNG Project. Fine-mapping the breakpoint junctions of 259 ASD-relevant duplications identified 34 (13.1%) variants with complex genomic structures as well as tandem (193/259, 74.5%) and NAHR- mediated (6/259, 2.3%) duplications. As whole genome sequencing-based studies expand in scale and reach, a continued focus on generating high-quality, standardized duplication data will be prerequisite to addressing their associated biological mechanisms. ii Acknowledgements I thank Dr. Stephen Scherer for his leadership par excellence, his generosity, and for giving me a chance. I am grateful for his investment and the opportunities afforded me, from which I have learned and benefited. I would next thank Drs. -
Apoptosis Inhibitor of Macrophage (AIM) Is Required for Obesity-Associated Recruitment of Inflammatory Macrophages Into Adipose Tissue
Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue Jun Kurokawaa, Hiromichi Naganoa, Osamu Oharab, Naoto Kubotac, Takashi Kadowakic, Satoko Araia, and Toru Miyazakia,1 aLaboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan; bDepartment of Human Genome Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan; and cDepartment of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan Edited* by Tadatsugu Taniguchi, University of Tokyo, Tokyo, Japan, and approved June 14, 2011 (received for review February 3, 2011) Infiltration of inflammatory macrophages into adipose tissues with macrophages against different types of apoptosis-inducing stimuli the progression of obesity triggers insulin resistance and obesity- (13). AIM is a direct target for regulation by nuclear receptor liver related metabolic diseases. We recently reported that macrophage- X receptor/retinoid X receptor (LXR/RXR) heterodimers (15, derived apoptosis inhibitor of macrophage (AIM) protein is in- 16) and is solely produced by tissue macrophages. As a secreted molecule, AIM is detected in both human and mouse blood at creased in blood in line with obesity progression and is incorporated – into adipocytes, thereby inducing lipolysis in adipose tissue. Here various levels (13, 16 19) and increases in blood with the pro- we show that such a response is required for the recruitment of gression of obesity in mice fed a high-fat diet (HFD) (14). The augmented blood AIM induced lipolysis, as evident by the fact adipose tissue macrophages. -
Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ...................................................... -
Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.